ArticleActa dermato-venereologica2022

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data.

Alice B Gottlieb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.